These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4078031)

  • 1. The comparative bioavailability of liquid, wax-matrix, and microencapsulated preparations of potassium chloride.
    Skoutakis VA; Acchiardo SR; Wojciechowski NJ; Carter CA; Melikian AP; Chremos AN
    J Clin Pharmacol; 1985; 25(8):619-21. PubMed ID: 4078031
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of wax matrix and microencapsulated potassium chloride in relation to upper gastrointestinal illness requiring hospitalization.
    Jick H; Jick SS; Walker AM; Stergachis A
    Pharmacotherapy; 1989; 9(4):204-6. PubMed ID: 2771805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid and solid potassium chloride: bioavailability and safety.
    Skoutakis VA; Acchiardo SR; Wojciechowski NJ; Carter CA
    Pharmacotherapy; 1984; 4(6):392-7. PubMed ID: 6514589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single blind normal volunteer bioavailability study of a new microencapsulated potassium chloride tablet compared with two reference potassium formulations.
    Caplain H; Dahan R; Pamphile R; Thebault JJ
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):241-4. PubMed ID: 1814742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetics of a new, slow-release potassium chloride capsule.
    Arnold J; Jacob JT; Riley B
    J Pharm Sci; 1980 Dec; 69(12):1416-8. PubMed ID: 7463329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage of potassium chloride elixir to correct thiazide-induced hypokalemia.
    Schwartz AB; Swartz CD
    JAMA; 1974 Nov; 230(5):702-4. PubMed ID: 4606449
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation and release characteristics of potassium chloride microcapsules.
    Harris MS
    J Pharm Sci; 1981 Apr; 70(4):391-4. PubMed ID: 7229950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of a new potassium chloride delayed-action preparation in cardiopathy patients].
    Tronconi L; Recusani F; Sgalambro A; Raisaro A; Chinea B
    Clin Ter; 1982 Aug; 102(4):369-77. PubMed ID: 7140187
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioavailability of potassium from three dosage forms: suspension, capsule, and solution.
    Melikian AP; Cheng LK; Wright GJ; Cohen A; Bruce RE
    J Clin Pharmacol; 1988 Nov; 28(11):1046-50. PubMed ID: 3243918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium chloride: absorption and excretion.
    Levene DL
    Can Med Assoc J; 1973 Apr; 108(7):853-5. PubMed ID: 4707232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioavailability of potassium chloride from delayed-action preparations].
    Holzgreve H; Stephan R
    Med Welt; 1978 Oct; 29(43):1702-6. PubMed ID: 713790
    [No Abstract]   [Full Text] [Related]  

  • 12. Potassium supplementation during diuretic therapy.
    Cooper I
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):555-63. PubMed ID: 808378
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypokalemia, potassium loss and liver cirrhosis. Value of potassium chloride sustained-release tablets].
    Lévy VG; Caroli J
    Therapeutique; 1971 Dec; 47(10):845-51. PubMed ID: 5145546
    [No Abstract]   [Full Text] [Related]  

  • 14. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia.
    Wuermser LA; Reilly C; Poindexter JR; Sakhaee K; Pak CY
    Kidney Int; 2000 Feb; 57(2):607-12. PubMed ID: 10652038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of potassium balance disturbances by parenteral administration of large doses of potassium chloride in patients operated upon under conditions of extracorporeal circulation. 2].
    Solov'ev GM; Radzivil GG; Mikheeva EV
    Kardiologiia; 1969 Nov; 9(11):60-9. PubMed ID: 5369816
    [No Abstract]   [Full Text] [Related]  

  • 16. Upper gastrointestinal tract bleeding from oral potassium chloride. Comparative risk from microencapsulated vs wax-matrix formulations.
    Strom BL; Carson JL; Schinnar R; Sim E; Maislin G; Soper K; Morse ML
    Arch Intern Med; 1987 May; 147(5):954-7. PubMed ID: 3495244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse effects of diuretics: diuretics and potassium].
    Kitaoka T; Takahashi K; Koshikawa S
    Nihon Rinsho; 1984 Sep; 42(9):2086-92. PubMed ID: 6394804
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment: KCl formulations.
    Drug Intell Clin Pharm; 1987 Oct; 21(10):836-8. PubMed ID: 3428146
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of potassium chloride in wax-based and syrup formulations.
    Toner JM; Ramsay LE
    Br J Clin Pharmacol; 1985 Apr; 19(4):489-94. PubMed ID: 3994896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic-induced hypokalemia.
    Schwartz AB
    Am Fam Physician; 1975 Jan; 11(1):101-4. PubMed ID: 1109534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.